Literature DB >> 18058329

Drug-metabolizing enzymes in the skin of man, rat, and pig.

Franz Oesch1, Eric Fabian, Barbara Oesch-Bartlomowicz, Christoph Werner, Robert Landsiedel.   

Abstract

The mammalian skin has long been considered to be poor in drug metabolism. However, many reports clearly show that most drug metabolizing enzymes also occur in the mammalian skin albeit at relatively low specific activities. This review summarizes the current state of knowledge on drug metabolizing enzymes in the skin of human, rat, and pig, the latter, because it is often taken as a model for human skin on grounds of anatomical similarities. However only little is known about drug metabolizing enzymes in pig skin. Interestingly, some cytochromes P450 (CYP) have been observed in the rat skin which are not expressed in the rat liver, such as CYP 2B12 and CYP2D4. As far as investigated most drug metabolizing enzymes occur in the suprabasal (i.e. differentiating) layers of the epidermis, but the rat CYP1A1 rather in the basal layer and human UDP-glucuronosyltransferase rather in the stratum corneum. The pattern of drug metabolizing enzymes and their localization will impact not only the beneficial as well as detrimental properties of drugs for the skin but also dictate whether a drug reaches the blood flow unchanged or as activated or inactivated metabolite(s).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18058329     DOI: 10.1080/03602530701690366

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  17 in total

1.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

2.  Human mitochondrial cytochrome P450 27C1 is localized in skin and preferentially desaturates trans-retinol to 3,4-dehydroretinol.

Authors:  Kevin M Johnson; Thanh T N Phan; Matthew E Albertolle; F Peter Guengerich
Journal:  J Biol Chem       Date:  2017-07-12       Impact factor: 5.157

Review 3.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

Review 4.  Skin Physiology of the Neonate and Infant: Clinical Implications.

Authors:  Teresa Oranges; Valentina Dini; Marco Romanelli
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-10-01       Impact factor: 4.730

Review 5.  Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; K Guth; R Landsiedel
Journal:  Arch Toxicol       Date:  2014-11-05       Impact factor: 5.153

6.  Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations.

Authors:  Guinevere H Bell; Andrew J Novak; William C Griffin; Kennerly S Patrick
Journal:  J Pharm Sci       Date:  2011-01-14       Impact factor: 3.534

7.  Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling.

Authors:  Sven van Eijl; Zheying Zhu; John Cupitt; Magdalena Gierula; Christine Götz; Ellen Fritsche; Robert J Edwards
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

8.  Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.

Authors:  Priyanka Ghosh; DoMin Lee; Kyung Bo Kim; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2013-08-14       Impact factor: 4.200

Review 9.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

10.  The skin function: a factor of anti-metabolic syndrome.

Authors:  Shi-Sheng Zhou; Da Li; Yi-Ming Zhou; Ji-Min Cao
Journal:  Diabetol Metab Syndr       Date:  2012-04-26       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.